Metformin HydrochlorideThird Party Manufacturing in India

Metformin Hydrochloride works by decreasing hepatic glucose production and improving insulin sensitivity.

It activates AMP-activated protein kinase (AMPK) in the liver, which suppresses gluconeogenesis (the production of glucose) and enhances peripheral glucose uptake and utilization by muscles. This dual action helps the body respond better to its own insulin and lowers blood glucose levels without stimulating additional insulin secretion.

Unlike sulfonylureas, Metformin Hydrochloride does not cause hypoglycemia when used as monotherapy. It is highly effective and well-tolerated for adult and pediatric patients with type 2 diabetes mellitus, often leading to weight neutrality or modest weight loss.

Therapeutic Uses

Metformin Hydrochloride is prescribed for the treatment of:

• Type 2 Diabetes Mellitus: Used as a first-line therapy alongside diet and exercise to improve glycemic control in adults and children.
• Polycystic Ovary Syndrome (PCOS): Frequently prescribed off-label to manage insulin resistance and improve ovulatory function in women with PCOS.
• Metabolic Syndrome: Used to manage metabolic risks associated with certain conditions or medications, improving overall insulin sensitivity.

Why Manufacturers Choose Metformin Hydrochloride

Metformin Hydrochloride is the cornerstone of type 2 diabetes management globally, ensuring massive, sustained demand. Its established safety profile, efficacy, and suitability for long-term use make it a staple in any antidiabetic portfolio.

This makes Metformin Hydrochloride one of the most sought-after molecules for third party manufacturing in India, with consistent demand from PCD franchise operators and export-oriented companies looking to supply high-volume, essential medications.